Peptides researched for bone density, osteoporosis prevention, and skeletal health.
5 peptides
FDA-approved synthetic PTHrP(1-34) analog that stimulates new bone formation and reduces vertebral (86% RRR) and nonvertebral (43% RRR) fracture risk...
FDA-approved synthetic 32-amino-acid polypeptide identical to salmon calcitonin, used for postmenopausal osteoporosis, Paget's disease, and...
Teriparatide is an FDA-approved recombinant PTH(1-34) analog that stimulates new bone formation for the treatment of osteoporosis. The pivotal...
Eneboparatide (AZP-3601) is an investigational PTH1 receptor agonist developed by Amolyt Pharma (now Alexion/AstraZeneca) for chronic...
Retatrutide (LY3437943) is an investigational triple agonist for the GIP, GLP-1, and glucagon receptors developed by Eli Lilly. Phase 2 trials showed...